Suppr超能文献

通过新型缓释星形药物递送装置滥用噻奈普汀

"Tianeptine abuse via novel, extended-release, star-shaped, drug delivery device".

作者信息

Galust Henrik, Seltzer Justin A, Hardin Jeremy R, Friedman Nathan A, Minns Alicia

机构信息

UCSD Fellowship in Medical Toxicology, Department of Emergency Medicine, UCSD Medical Center, 200W. Arbor Dr. #8676, San Diego, CA 92103, USA.

出版信息

Toxicol Rep. 2023 Aug 1;11:162-164. doi: 10.1016/j.toxrep.2023.07.006. eCollection 2023 Dec.

Abstract

We report a rare domestic case of exposure to tianeptine and use of a novel, extended-release, six-armed, star-shaped, drug delivery capsule. A 40-year-old male with a history of depression, anxiety, ethanol, opioid, cannabis, and tobacco use disorders presented to the emergency department (ED) from a substance abuse residential recovery treatment program after developing hypertension, tachycardia, and tremor for two day. He used an extended-release, six-armed, star-shaped, drug delivery device he purchased online, filling each arm with 15 mg of tianeptine (90 mg total). His intention was to mitigate the symptoms of kratom/opioid withdrawal through this extended-release method while simultaneously undergoing formal treatment for ethanol withdrawal. Tianeptine is an atypical tricyclic antidepressant that exerts complex mechanisms of action including serotonin (5-HT) neuromodulation as well as full μ-opioid and ∂-opioid receptor agonism. The capsule itself is made of caprolactone, which is a bioabsorbable material similar to absorbable sutures, initially developed as a long-term enteral antimalarial delivery method and is not FDA approved for human use. Over the course of the patients two day hospitalization course he developed symptoms consistent with uncomplicated ethanol withdrawal, which were treated with as-needed phenobarbital. No clinical manifestations of opioid or serotonin toxicity developed. Serial EKGs and telemetry monitoring remained unchanged. The patient was then medically cleared and discharged back to the residential recovery treatment program.

摘要

我们报告一例罕见的国内天奈普汀暴露病例,并介绍一种新型的、缓释的、六臂星形药物递送胶囊的使用情况。一名40岁男性,有抑郁症、焦虑症、乙醇、阿片类药物、大麻和烟草使用障碍史,在出现高血压、心动过速和震颤两天后,从一个药物滥用住院康复治疗项目被送至急诊科。他使用了一个在网上购买的缓释、六臂星形药物递送装置,每个臂中填充15毫克天奈普汀(共90毫克)。他的意图是通过这种缓释方法减轻 kratom/阿片类药物戒断症状,同时接受乙醇戒断的正规治疗。天奈普汀是一种非典型三环类抗抑郁药,其作用机制复杂,包括5-羟色胺(5-HT)神经调节以及完全的μ-阿片受体和δ-阿片受体激动作用。该胶囊本身由己内酯制成,己内酯是一种与可吸收缝线类似的生物可吸收材料,最初被开发为一种长期的肠道抗疟疾递送方法,未获得美国食品药品监督管理局(FDA)的人体使用批准。在患者两天的住院过程中,他出现了与单纯乙醇戒断相符的症状,用按需使用的苯巴比妥进行了治疗。未出现阿片类药物或5-羟色胺毒性的临床表现。连续心电图和遥测监测未发生变化。然后该患者经医学评估后出院,返回住院康复治疗项目。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cf/10407812/084864375adb/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验